Camila Squarzoni Dale: “Putative Mechanisms involved on motor cortex stimulation: what do we learn from experimenatl models”

2016年09月23日  13:30 〜 15:00

CiNet 1F 大会議室

Camila Squarzoni Dale

Assistant Professor
University of Sao Paulo

担当 : 小林 康 (大澤グループ)

Abstract:

Cortical electrical stimulation (CES) has shown to be an effective therapeutic alternative for neuropathic pain refractory to pharmacological treatment. However, current CES modalities still fail to relieve pain in a significant proportion of individuals. To better understand the mechanism by which CES induces antinociception is one way to improve their efficacy is to search for new stimulation targets. In this talk I will present the most recent data on animal studies on the antinociception induced by CES in rats as well as the mechanisms involved in such effect. Also, looking for new targets for the treatment of refractory pain I will also present some data on electrical stimulation of the insular cortex of rats with neuropathic pain.

Prof. Camila Squarzoni Dale is a basic researcher interested in neuromodulation with focus on chronic experimental pain.
She obtained her PhD from the University of Sao Paulo, Brazil, and underwent a two-year post-doctoral program in Toulouse France. She is currently the Assistant Professor at the Department of anatomy and head of the Laboratory of Neuromodulation of Experimental Pain.
She has over 25 publications in peer reviewed Journals, she has won scholarship prizes from the Brasilian Association of Pain and serves as a reviewer for the Journal of Pain, Behavioral and Brain research and Peptides.
In this talk entitled ” Putative Mechanisms involved on motor cortex stimulation: what do we learn from experimental models” Prof Dale will review the main data on animal studies on the antinociception induced by CES in rats as well as the mechanisms involved in such effect. Also, looking for new targets for the treatment of refractory pain I will also present some data on electrical stimulation of the insular cortex of rats with neuropathic pain as a new target for pain relief.